Insmed | INSM - Trade Debtors

Stock Price
160.18
Daily Change
-2.85 -1.75%
Monthly
11.91%
Yearly
137.13%
Q2 Forecast
157.54

Insmed reported $140.86M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025